Viavi (VIAV) Form 4: 6,768 RSUs Awarded to Director

Rhea-AI Filing Summary

Viavi Solutions Inc. (VIAV) director Eugenia Corrales received an award of 6,768 restricted stock units (RSUs) on 08/28/2025. The RSUs were granted at a $0 exercise/conversion price and are reported as directly owned following the transaction, with 6,768 shares underlying the award. The units vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, and the filing states there is no expiration date on the RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/29/2025.

Positive

• Grant increases director's direct ownership by 6,768 RSUs, aligning interests with shareholders
• Simple, time-based vesting (earlier of one year or next annual meeting) provides clear retention terms

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity award disclosed; standard time-based vesting with no expiration.

The filing documents a standard issuance of 6,768 restricted stock units to a company director, with vesting tied to time/events (one year or next annual meeting). This is a common mechanism to align director incentives with shareholder interests and to ensure retention through time-based vesting. The award is reported as directly beneficially owned and carries no stated expiration, consistent with typical RSU grants for non-employee directors.

Compensation Analyst

TL;DR: Non-cash RSU grant of 6,768 shares recorded; vesting schedule is simple and short-term.

The transaction shows an RSU grant at a $0 conversion price, indicating a standard restricted equity award rather than an option. Vesting is the earlier of one year or the next annual meeting, which suggests a short-term vesting condition often used for newly granted director awards or to bridge timing to the company’s annual grant cycle. The grant increases the director's reported beneficial ownership by the stated amount.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Corrales Eugenia

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS, INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER AZ 85286

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0	08/28/2025		A		6,768		(1)	(2)	Common Stock	6,768	$0	6,768	D

Explanation of Responses:

1. Units subject to the award shall vest on the earlier of the one year anniversary of the grant or the next Annual Meeting of Stockholders.

2. There are no expiration dates on RSUs.

	/s/ Donna T. Rossi, attorney-in-fact	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Eugenia Corrales report on Form 4 for VIAV?

The Form 4 reports a grant of 6,768 restricted stock units (RSUs) on 08/28/2025.

What is the vesting schedule for the RSUs reported on VIAV Form 4?

The RSUs vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders.

How many shares does the reported RSU award convert into for VIAV?

The award covers 6,768 underlying shares of common stock, and the reporting person beneficially owns 6,768 following the transaction.

Was there a cash exercise price for the RSUs in the VIAV Form 4?

No; the filing shows a $0 conversion/exercise price for the restricted stock units.

Who signed the Form 4 for the reporting person and when?

The Form 4 was signed by Donna T. Rossi, attorney-in-fact on 08/29/2025.